Long‐term efficacy of tenofovir monotherapy for hepatitis B virus‐monoinfected patients after failure of nucleoside/nucleotide analogues
暂无分享,去创建一个
T. Berg | U. Spengler | J. Trojan | B. Wiedenmann | C. Sarrazin | R. D. de Man | H. Wedemeyer | A. Erhardt | P. Buggisch | D. Hüppe | H. Wasmuth | J. Petersen | B. Möller | K. Deterding | W. Böcher | K. Stein | H. Feucht | F. van Bömmel | P. Rhode | Jurrien G.P. Reinders
[1] A. Lok,et al. Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. , 2008, Journal of hepatology.
[2] M. Manns,et al. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection. , 2007, Zeitschrift fur Gastroenterologie.
[3] V. Johnson,et al. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127 , 2006, Hepatology.
[4] R. Bruno,et al. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection , 2006, AIDS.
[5] T. Berg,et al. Tenofovir for patients with lamivudine‐resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy , 2006, Hepatology.
[6] Michael D. Miller,et al. Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus , 2006, Antimicrobial Agents and Chemotherapy.
[7] Huiling Yang,et al. In Vitro Susceptibility of Adefovir-Associated Hepatitis B Virus Polymerase Mutations to other Antiviral Agents , 2006, Antiviral therapy.
[8] P. Lampertico,et al. Adefovir rapidly suppresses hepatitis B in HBeAg‐negative patients developing genotypic resistance to lamivudine , 2005, Hepatology.
[9] E. Clercq,et al. Acyclic nucleoside phosphonates: a key class of antiviral drugs , 2005, Nature Reviews Drug Discovery.
[10] H. Janssen,et al. Viral dynamics during tenofovir therapy in patients infected with lamivudine‐resistant hepatitis B virus mutants , 2005, Journal of viral hepatitis.
[11] Huiling Yang,et al. Cross-Resistance Testing of Next-Generation Nucleoside and Nucleotide Analogues against Lamivudine-Resistant HBV , 2005, Antiviral therapy.
[12] T. Berg,et al. Comparison of adefovir and tenofovir in the treatment of lamivudine‐resistant hepatitis B virus infection , 2004, Hepatology.
[13] Joel E Gallant,et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. , 2004, JAMA.
[14] C. Katlama,et al. In Vitro Susceptibility of Lamivudine-Resistant Hepatitis B Virus to Adefovir and Tenofovir , 2003, Antiviral therapy.
[15] R. Tubiana,et al. Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus. , 2003, The New England journal of medicine.
[16] V. Soriano,et al. Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine. , 2002, AIDS.
[17] T. Berg,et al. Tenofovir treatment in patients with lamivudine‐resistant hepatitis B mutants strongly affects viral replication , 2002, Hepatology.
[18] D. Richman,et al. Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region , 2001, Hepatology.
[19] K. Walters,et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine , 1998 .
[20] S. Löfdahl,et al. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. , 1992, The Journal of general virology.
[21] J. Stockman,et al. Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B , 2010 .
[22] T. Berg,et al. 76 TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN SUBJECTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL (ADV) , 2008 .
[23] D. Richman,et al. Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region , 2001, Hepatology.